Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

Publication | Open Access

DOI Full Paper Access

Citations

References

2021

Year

Adam G. Stewart, David L. Paterson, Barnaby Edward Young, David Chien Lye, Joshua S. Davis, Kellie E. Schneider, Mesut Yılmaz, Rumeysa Dinleyici, Naomi Runnegar, Andrew Henderson,

Open Forum Infectious Diseases

Abstract

References